Comparative effects of pranidipine with amlodipine in rats with heart failure

Pharmacology
Punniyakoti T VeeraveeduYoshifusa Aizawa

Abstract

The aim of the present study was to compare the cardioprotective properties of long-acting calcium channel antagonist pranidipine with amlodipine in rat model of heart failure induced by autoimmune myocarditis. Twenty-eight days after immunization the surviving rats were randomized for the oral administration of low-dose amlodipine (1 mg/kg/day), high-dose amlodipine (5 mg/kg/day), pranidipine (0.3 mg/kg/day) or vehicle (0.5% methylcellulose). After oral administration for 1 month, the animals underwent echocardiography and hemodynamic analysis. Histopathology, immunohistochemistry, and Western immunoblotting were carried out in the heart samples. Both pranidipine and high-dose amlodipine increased survival rate. Although the heart rate did not differ among the four groups, left ventricular end-diastolic pressure was significantly decreased and +/-dP/dt was increased in the pranidipine- and high-dose amlodipine-treated rats, but not in low-dose amlodipine-treated rats. In comparison to amlodipine treatment, pranidipine treatment significantly reduced myocyte size and central venous pressure. Furthermore, both pranidipine and high-dose amlodipine treatment significantly reduced myocardial protein levels of atrial natriuretic pep...Continue Reading

References

Jan 1, 1991·Journal of Cardiovascular Pharmacology·W G Nayler, S Britnell
Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Aug 1, 1990·Circulation·M R Bristow
Jan 11, 1990·The New England Journal of Medicine·A M Katz
May 1, 1989·The Journal of Clinical Investigation·J GutkowskaP Sirois
Dec 1, 1989·Biochemical Pharmacology·D R Janero, B Burghardt
Jun 1, 1983·Journal of Medicinal Chemistry·R A Janis, D J Triggle
Aug 1, 1994·Circulation Research·M KodamaA Shibata
Jan 27, 1994·The American Journal of Cardiology·R Burges, D Moisey
May 1, 1996·American Heart Journal·C Lin, W H Frishman
Oct 20, 1998·Circulation·F G SpinaleM G Dodd
Nov 5, 1999·Cardiovascular Drugs and Therapy·C S KimJ K Gwathmey
Aug 6, 2000·British Journal of Pharmacology·K WatanabeY Aizawa
Apr 18, 2001·Cellular Signalling·M Silberbach, C T Roberts
Nov 3, 2001·Journal of the American College of Cardiology·N NishikawaM Hori
Jun 17, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Zuyi YuanKeisuke Shioji
Apr 21, 2004·Blood Pressure Monitoring·Décio MionFernando Nobre
Apr 13, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Seiji UmemotoMasunori Matsuzaki

❮ Previous
Next ❯

Citations

Mar 1, 2012·Journal of the American College of Cardiology·Ingrid KindermannMichael Böhm
Nov 20, 2016·Expert Review of Cardiovascular Therapy·George LazarosDimitris Tousoulis
Nov 2, 2019·Basic Research in Cardiology·Joshua A SilverblattDaniel I Bromage

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.